Status:
UNKNOWN
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
Lead Sponsor:
Ain Shams University
Conditions:
Coronavirus (COVID-19)
Eligibility:
All Genders
Brief Summary
The following two mechanisms that explain the ability of measles vaccine to cause partial protection against COVID-19. The first is that measles vaccine may increase the ability of the immune system t...
Detailed Description
Objectives: 1. To identify Measles IgG titre in SARS-COV2 infected patients . 2. correlate level of Measles IgG titre with the clinical severity of COVID-19 disease. Secondary Objective To find an a...
Eligibility Criteria
Inclusion
- All patients with confirmed COVID 19.
- Any age or gender
Exclusion
- \- Any patient refusing to be involved in the study
Key Trial Info
Start Date :
July 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04445610
Start Date
July 1 2020
End Date
November 1 2020
Last Update
June 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine Ain Shams University Research Institute- Clinical Research Center
Cairo, Non-US, Egypt, 11566